The recent launch of the Pandemic Emergency Financing Facility by the World Bank in partnership with World Health Organisation, Swiss Re and Munich Re, marks a timely and much-awaited milestone in innovative contingent funding for low-income economies impacted by infectious disease pandemics (Robin Harding, FT, 21 May 2016). The Ebola outbreak which impacted parts of West Africa wrecked the economies of Sierra Leone, Guinea and Liberia, costing $10 billion and 12,000 lives. The financial and epidemiological setbacks could...read full post
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.